Filing Details
- Accession Number:
- 0001209191-21-052277
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-18 17:25:23
- Reporting Period:
- 2021-08-16
- Accepted Time:
- 2021-08-18 17:25:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1662774 | Cortexyme Inc. | CRTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376260 | P. Christopher Lowe | C/O Cortexyme, Inc. 269 East Grand Ave. South San Francisco CA 94080 | Coo & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-16 | 22,000 | $2.23 | 52,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-16 | 9,158 | $94.23 | 42,842 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-16 | 7,335 | $95.02 | 35,507 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-16 | 2,330 | $96.32 | 33,177 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-16 | 1,100 | $97.28 | 32,077 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-16 | 2,077 | $98.90 | 30,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-08-17 | 30,000 | $2.23 | 60,000 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-08-16 | 22,000 | $0.00 | 22,000 | $2.23 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-08-17 | 30,000 | $0.00 | 30,000 | $2.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 163,294 | 2028-11-27 | No | 4 | M | Direct | |
| 133,294 | 2028-11-27 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.63 to $94.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.66 to $95.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.68 to $96.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.89 to $97.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The option vested as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022.
Billionaire Hedge Funds
